These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 19182518)
1. Balancing the decision of cell proliferation and cell fate. Hallstrom TC; Nevins JR Cell Cycle; 2009 Feb; 8(4):532-5. PubMed ID: 19182518 [TBL] [Abstract][Full Text] [Related]
2. C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions. Schertel C; Conradt B Development; 2007 Oct; 134(20):3691-701. PubMed ID: 17881492 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system. Sengupta S; Henry RW Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102 [TBL] [Abstract][Full Text] [Related]
4. The Retinoblastoma pathway regulates stem cell proliferation in freshwater planarians. Zhu SJ; Pearson BJ Dev Biol; 2013 Jan; 373(2):442-52. PubMed ID: 23123964 [TBL] [Abstract][Full Text] [Related]
5. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Chen HZ; Tsai SY; Leone G Nat Rev Cancer; 2009 Nov; 9(11):785-97. PubMed ID: 19851314 [TBL] [Abstract][Full Text] [Related]
6. The RB/E2F pathway and regulation of RNA processing. Ahlander J; Bosco G Biochem Biophys Res Commun; 2009 Jul; 384(3):280-3. PubMed ID: 19401190 [TBL] [Abstract][Full Text] [Related]
7. E2F - at the crossroads of life and death. Polager S; Ginsberg D Trends Cell Biol; 2008 Nov; 18(11):528-35. PubMed ID: 18805009 [TBL] [Abstract][Full Text] [Related]
8. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1. Rogoff HA; Kowalik TF Cell Cycle; 2004 Jul; 3(7):845-6. PubMed ID: 15190206 [TBL] [Abstract][Full Text] [Related]
9. A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest. Angus SP; Nevins JR Oncogene; 2012 Nov; 31(44):4709-17. PubMed ID: 22249253 [TBL] [Abstract][Full Text] [Related]
10. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter. Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440 [TBL] [Abstract][Full Text] [Related]
11. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445 [TBL] [Abstract][Full Text] [Related]
12. The transcription factor E2F: a crucial switch in the control of homeostasis and tumorigenesis. Fang ZH; Han ZC Histol Histopathol; 2006 Apr; 21(4):403-13. PubMed ID: 16437386 [TBL] [Abstract][Full Text] [Related]
13. A bistable Rb-E2F switch underlies the restriction point. Yao G; Lee TJ; Mori S; Nevins JR; You L Nat Cell Biol; 2008 Apr; 10(4):476-82. PubMed ID: 18364697 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the Arf/p53 tumor surveillance network by E2F. Iaquinta PJ; Aslanian A; Lees JA Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767 [TBL] [Abstract][Full Text] [Related]
15. Emerging links between E2F control and mitochondrial function. Benevolenskaya EV; Frolov MV Cancer Res; 2015 Feb; 75(4):619-23. PubMed ID: 25634216 [TBL] [Abstract][Full Text] [Related]
16. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Cayrol C; Lacroix C; Mathe C; Ecochard V; Ceribelli M; Loreau E; Lazar V; Dessen P; Mantovani R; Aguilar L; Girard JP Blood; 2007 Jan; 109(2):584-94. PubMed ID: 17003378 [TBL] [Abstract][Full Text] [Related]
17. Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator. Zhu L Eur J Cancer; 2005 Nov; 41(16):2415-27. PubMed ID: 16209920 [TBL] [Abstract][Full Text] [Related]
19. Origin of bistability underlying mammalian cell cycle entry. Yao G; Tan C; West M; Nevins JR; You L Mol Syst Biol; 2011 Apr; 7():485. PubMed ID: 21525871 [TBL] [Abstract][Full Text] [Related]
20. CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer. Hu J; Shen J; Sun J Biomed Pharmacother; 2020 May; 125():109870. PubMed ID: 32032891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]